Interesting KYMR Put And Call Options For January 2026

The article details options strategies for Kymera Therapeutics (KYMR), presenting a cash-secured put at the $45.00 strike that offers a 28.70% annualized return if it expires worthless, or an effective purchase price of $41.00. For existing holders, a covered call at the $55.00 strike could yield an 18.16% total return if exercised, or a 40.32% annualized premium if it expires worthless. These strategies illustrate methods to enhance yield or acquire shares at a discount, noting KYMR's implied volatilities (89% for the put, 84% for the call) are elevated compared to its 71% historical volatility.

Analysis

The options market for Kymera Therapeutics (KYMR) presents opportunities for yield generation and discounted stock acquisition, primarily driven by elevated implied volatility. The implied volatility for the January 2026 put (89%) and call (84%) options are notably higher than the stock's trailing twelve-month actual volatility of 71%, suggesting that options are richly priced. For investors interested in acquiring the stock, selling the $45 strike put offers an effective entry point at $41.00 per share (a 14% discount from the current $52.05 price) if assigned. If the put expires worthless, which has a 71% probability according to the provided data, the seller captures an 8.89% return on cash collateral, or 28.70% annualized. For existing shareholders, selling the $55 strike covered call provides a 12.49% premium boost (40.32% annualized) if the option expires worthless, with a 45% probability. If the stock is called away, the strategy yields a total return of 18.16%, capping further upside potential. These strategies are fundamentally volatility-selling plays, designed to capitalize on the premium between implied and historical volatility.

Key Decisions for Investors

• Investors bullish on KYMR but seeking a lower entry point could consider selling the $45 cash-secured put to either acquire shares at an effective cost basis of $41.00 or generate a 28.70% annualized yield.
• Current KYMR shareholders could sell the $55 covered call to generate significant income, but must be willing to cap their upside and sell their shares at an effective price of $61.50 ($55 strike + $6.50 premium), for a total return of 18.16%.
• Given that implied volatility (84-89%) is significantly above historical volatility (71%), these strategies are attractive for option sellers, but investors must recognize this also signals market expectation of large price swings which could lead to assignment or missed upside.